Drupal.behaviors.print = function(context) {window.print();window.close();}>
Alnylam Doses First Patients in Cholesterol Drug Trial
September 29, 2011
Alnylam Doses First Patients in Cholesterol Drug Trial
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
Alnylam Finds Partner for Cholesterol Program in The Medicines Company
February 7, 2013 / Gene Silencing News
Alnylam ATTR Program on Track as Company Explores Subcutaneous Delivery for Cholesterol Drug
November 8, 2012 / Gene Silencing News
As Alnylam Files to Begin Testing Cholesterol Drug in Humans, Questions Linger Over Delivery Tech
July 14, 2011 / Gene Silencing News
IP Update: Recent Patents, Patent Applications Awarded to UNC, Alnylam, FSU, and More
February 7, 2013 / Gene Silencing News
Oligo Drugs Advance in the Clinic in 2012 as Delivery Hurdles are Addressed
January 3, 2013 / Gene Silencing News